313736-34-4

Basic information

• Product Name: 1H-1-Benzazepine-4-carboxylic acid, 7-[4-(2-butoxyethoxy)phenyl]-2,3-dihydro-1-(2-methylpropyl)-
• CAS NO: 313736-34-4
• Molecular Formula: C27H35NO4
• Molecular Weight: 437.579
• Mol File: 313736-34-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1H-1-Benzazepine-4-carboxylic acid, 7-[4-(2-butoxyethoxy)phenyl]-2,3-dihydro-1-(2-methylpropyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-1-Benzazepine-4-carboxylic acid, 7-[4-(2-butoxyethoxy)phenyl]-2,3-dihydro-1-(2-methylpropyl)-(313736-34-4)
• EPA Substance Registry System: 1H-1-Benzazepine-4-carboxylic acid, 7-[4-(2-butoxyethoxy)phenyl]-2,3-dihydro-1-(2-methylpropyl)-(313736-34-4)

Safety Data

• Hazardous Substances Data: 313736-34-4(Hazardous Substances Data)

Upstream product

• 313735-42-1 7-bromo-2,3-dihydro-1H-1-benzazepine-4-carboxylic acid 
• 279262-28-1 {4-[2-(butoxy)ethoxy]phenyl}boronic acid 
• 313724-44-6 methyl 7-bromo-2,3-dihydro-1H-benzo[b]azepine-4-carboxylate 
• 39255-24-8 1-bromo-4-[2-(butoxy)ethoxy]benzene 
• 52727-57-8 5-bromo-2-aminobenzoic acid methyl ester 
• 10503-96-5 1-(2-chloroethoxy)butane 
• 106-41-2 4-bromo-phenol 
• 3951-89-1 7-bromo-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one 
• 313736-13-9 methyl 7-bromo-1-isobutyl-2,3-dihydro-1H-1-benzazepine-4-carboxylate 
• 93777-26-5 5-bromo-2-fluorobenzaldehyde 
• 2687-92-5 1-isobutyl-pyrrolidin-2-one 
• 854764-36-6 4-[(4-bromo-2-formyl-phenyl)-isobutyl-amino]-butyric acid 
• 313736-28-6 methyl 7-{4-[2-(butoxy)ethoxy]phenyl}-1-isobutyl-2,3-dihydro-1H-1-benzazepine-4-carboxylate 
• 313724-31-1 methyl 7-bromo-1-(t-butoxycarbonyl)-1,2,3,4-tetrahydro-1-benzazepin-5-one-4-carboxylate 

Downstream Products

• 597583-16-9 7-[4-(2-butoxy-ethoxy)-phenyl]-1-isobutyl-2,3-dihydro-1H-benzo[b]azepine-4-carbonyl chloride 
• 497851-55-5 7-[4-(2-butoxyethoxy)phenyl]-1-isobutyl-N-(4-hydroxyphenyl)-2,3-dihydro-1H-1-benzazepine-4-carboxamide 
• 497851-17-9 7-[4-(2-butoxyethoxy)phenyl]-1-isobutyl-N-[4-[(2-pyrimidinylamino)sulfonyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide 
• 497854-96-3 7-[4-(2-butoxyethoxy)phenyl]-N-(4-hydroxymethylphenyl)-2,3-dihydro-1-isobutyl-1H-1-benzazepine-4-carboxamide 
• 497850-34-7 7-{4-[2-(butoxy)ethoxy]phenyl}-1-isobutyl-N-({4-[(4-propyl-4H-1,2,4-triazol-3-yl)methyl]sulfanyl}phenyl)-2,3-dihydro-1H-1-benzazepine-4-carboxamide 
• 497853-26-6 7-[4-(2-butoxyethoxy)phenyl]-1-isobutyl-N-[4-[[[1-propylimidazol-5-yl]methyl]sulfanyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide 
• 497850-58-5 7-[4-(2-butoxyethoxy)phenyl]-1-isobutyl-N-[4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide 

Relevant articles and documents

Unusual asymmetric oxidation of sulfide; the diastereoselective oxidation of prochiral sulfide-chiral acid salt with hydrogen peroxide without metal

The sulfide 4 was treated with chiral acid in a mixture of toluene and methyl iso-butylketone to precipitate the salt, which reacted with 30% H 2O2 for 3 weeks at rt. The resulting crystals were collected followed by recrystallizatio

BENZAZEPINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF

Compounds of the general formula (I): or salts thereof, which exhibit CCR5 antagonism and exert preventive and therapeutic effects against HIV infections: wherein R1 is a 5- to 6-membered aromatic ring which bears a substituent represented by the general formula: R-Z1-X-Z2- (wherein R1 is hydrogen or optionally substituted hydrocarbyl; X is optionally substituted alkylene; and Z1 and Z2 are each a heteroatom) and may be further substituted, with R being optionally bonded to the aromatic ring to form another ring; Y is optionally substituted imino; and R2 and R3 are each optionally substituted aliphatic hydrocarbyl or an optionally substituted hetero-alicyclic group.